{"section":{"filename":"s2422.html","chapter":"2400","section_number":"2422","title":"Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25","revision_tag":"R-07.2022","bytes":246868,"sha256":"8df320536393e5c8ee157247847e1d9127b2e6adc801e1e94f5fb9176316513d","subsection_count":10,"max_depth":2,"subsections":[{"number":"2422.01","title":"Nucleotide and/or Amino Acids Disclosures Requiring a “Sequence Listing”","revision_tag":"R-07.2022","depth":1},{"number":"2422.02","title":"The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures","revision_tag":"R-07.2022","depth":1},{"number":"2422.03","title":"Sequence Listing Submission","revision_tag":"R-07.2022","depth":1},{"number":"2422.03(a)","title":"“Sequence Listing” Submitted as ASCII Plain Text Files","revision_tag":"R-01.2024","depth":2},{"number":"2422.04","title":"The Requirement for a Computer Readable Copy of the “Sequence Listing”","revision_tag":"R-07.2022","depth":1},{"number":"2422.05","title":"[Reserved]","revision_tag":null,"depth":1},{"number":"2422.06","title":"Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form","revision_tag":"R-07.2022","depth":1},{"number":"2422.07","title":"Requirements for Compliance and Consequences of Non-Compliance","revision_tag":"R-07.2022","depth":1},{"number":"2422.08","title":"Presumptions Regarding Compliance","revision_tag":"R-07.2022","depth":1},{"number":"2422.09","title":"[Reserved]","revision_tag":null,"depth":1}]},"quality":"source","cited_authorities":null,"structured_data":null}